Impact of the COVID-19 pandemic on patients suffering from musculoskeletal tumours.
Martin ThalerIsmail KhosraviAndreas LeithnerPanayiotis J PapagelopoulosPietro RuggieriPublished in: International orthopaedics (2020)
The SARS-CoV-2 pandemic caused a significant reduction in healthcare (surgery, radiotherapy, chemotherapy) for malignancies of the musculoskeletal system. Delaying or stopping these treatments is life-threatening or can cause severe morbidity, pain, and loss of function. Although the coronavirus disease causes severe medical complications, serious collateral damage including death due to delayed or untreated sarcomas should be avoided.
Keyphrases
- sars cov
- coronavirus disease
- healthcare
- end stage renal disease
- respiratory syndrome coronavirus
- minimally invasive
- ejection fraction
- early onset
- newly diagnosed
- early stage
- radiation therapy
- peritoneal dialysis
- prognostic factors
- oxidative stress
- coronary artery bypass
- squamous cell carcinoma
- radiation induced
- spinal cord injury
- acute coronary syndrome
- spinal cord
- rectal cancer